Radácsi Andrea, Kovács Gábor, Bernard Wolfdieter, Feldkamp Joachim, Horster Franz A, Szabolcs István
Division of Endocrinology, Department of Internal Medicine and Geriatrics, National Medical Center Budapest, Hungary.
Endocrine. 2003 Jul;21(2):133-6. doi: 10.1385/endo:21:2:133.
We investigated the natural course of subclinical thyroid dysfunctions in geriatric patients, especially regarding their association with mortality rate. Ninety-three randomly selected chronically ill geriatric patients 64- 87 (median: 77) yr of age participated in the screening study with a 2-yr follow-up. Serum thyrotropin (thyroid- stimulating hormone [TSH]), free thyroxine, triiodothyronine, and antibodies against thyroid peroxidase were measured. During the follow-up, patients with suppressed TSH levels who were otherwise euthyroid (untreated) had a higher mortality rate than patients with normal TSH (5/8 vs 18/64; p < 0.05). The initial clinical state of these two subgroups did not differ significantly. Two-thirds of patients with treated hyperthyroidism died. The mortality rate of patients with initially subnormal but not suppressed TSH level was average and did not differ statistically from either the euthyroid or the hyperthyroid groups. Only 1 of 13 euthyroid patients with positive thyroid antibody titers developed a subsequent subclinical hypothyroidism. Subclinical hyperthyroidism was found to be associated with a higher mortality rate in chronically ill geriatric patients, which justifies screening for thyroid dysfunction and treatment of subclinical hyperthyroidism. In addition, a subnormal but measurable TSH was not indicative regarding the future development of hyperthyroidism. Finally, during the 2-yr follow-up, antibody positivity in the euthyroid cases did not prove to be predictive for the subsequent development of hypothyroidism.
我们研究了老年患者亚临床甲状腺功能障碍的自然病程,特别是其与死亡率的关联。93名年龄在64 - 87岁(中位数:77岁)的随机选取的老年慢性病患者参与了这项为期2年随访的筛查研究。检测了血清促甲状腺激素(甲状腺刺激激素[TSH])、游离甲状腺素、三碘甲状腺原氨酸以及抗甲状腺过氧化物酶抗体。在随访期间,TSH水平被抑制但甲状腺功能正常(未治疗)的患者的死亡率高于TSH正常的患者(5/8 vs 18/64;p < 0.05)。这两个亚组的初始临床状态无显著差异。接受治疗的甲状腺功能亢进患者中有三分之二死亡。初始TSH水平低于正常但未被抑制的患者的死亡率处于平均水平,与甲状腺功能正常组或甲状腺功能亢进组在统计学上无差异。13名甲状腺抗体滴度呈阳性的甲状腺功能正常患者中只有1人随后出现了亚临床甲状腺功能减退。研究发现,亚临床甲状腺功能亢进与老年慢性病患者较高的死亡率相关,这证明了对甲状腺功能障碍进行筛查以及治疗亚临床甲状腺功能亢进的合理性。此外,TSH低于正常但可测量并不预示甲状腺功能亢进的未来发展。最后,在2年的随访期间,甲状腺功能正常病例中的抗体阳性并未被证明可预测随后甲状腺功能减退的发生。